GlassScriptPhysician profile
Joseph Iobst
NPI 1366407819
$558.90
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2020: $25.88 · 2022: $110 · 2023: $185 · 2024: $44.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $207.45 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $70.61 | 2019-2022 | |
| Astellas Pharma US INC | $69.16 | 2023-2024 | Veozah, Myrbetriq |
| Avion Pharmaceuticals | $28.53 | 2019-2020 | |
| Lsi Solutions INC | $21.78 | 2023 | Ti Knot, Fornisee, Running Device |
| Olympus America INC. | $20.33 | 2023 | |
| Sumitomo Pharma America, INC. | $17.91 | 2023 | Myfembree |
| Boston Scientific Corporation | $16.79 | 2019 | |
| Coopersurgical, INC. | $15.88 | 2023 | Summit Doppler |
| Glaxosmithkline, LLC. | $15.78 | 2022 | |
| Lupin INC. | $15.30 | 2019 | |
| Exeltis, USA INC. | $13.32 | 2023 | Slynd |
| Minerva Surgical, INC | $12.47 | 2022 | |
| Allergan, INC. | $11.79 | 2019 | |
| Avanos Medical | $10.90 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $10.90 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Iobst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.